5013 ORAL FDG-PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-positive Breast Cancer Patients: the Neo-ALTTO Study Results

✍ Scribed by Gamez, C.; Flamen, P.; Holmes, E.; Robles, J.; Gebhart, G.; Di Cosimo, S.; Eidtmann, H.; Piccart-Gebhart, M.; Baselga, J.; De Azambuja, E.

• Book ID: 122953983
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 59 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71455-1